Latest Information Update: 15 Mar 2007
At a glance
- Originator Arkopharma
- Developer Arkopharma; Unknown
- Class Phytotherapies
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Chronic fatigue syndrome; HIV infections